BML-190

CAS: 2854-32-2

Ref. 3D-CAA85432

Información del producto

• Nombre: BML-190
• Sinónimos: (4-chlorophenyl)[5-methoxy-2-methyl-3-(2-morpholin-4-yl-2-oxoethyl)-2H-indol-2-yl]methanone, 1H-Indole, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-3-[2-(4-morpholinyl)-2-oxoethyl]-, 2-(1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)-1-morpholinoethanone, 2-[1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-1-(4-morpholinyl)ethanone, 2-[1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-1-(morpholin-4-yl)ethan-1-one, 2-[1-(4-Chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]-1-morpholin-4-ylethanone, Bml 190, Ethanone, 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-1-(4-morpholinyl)-, Indole, 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-[(morpholinocarbonyl)methyl]-, Lm-4131
• CAS: 2854-32-2

Descripción

BML-190 is a quinoline compound that inhibits the growth of cancer cells. It has antimicrobial activity and can bind to the CB2 receptor on cells, preventing the binding of endogenous cannabinoids. BML-190 also blocks the production of certain growth factors and erythropoietin, which may inhibit tumor proliferation. BML-190 has been shown to have anti-inflammatory properties in animal models. This drug has been shown to have anticancer effects in rat liver microsomes and colorectal carcinoma cells in vitro. BML-190 is not active against cryptococcus neoformans, although it inhibits pluripotent stem cell growth in vitro.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 426.89 g/mol
• Fórmula: C₂₃H₂₃ClN₂O₄
• Pureza: Min. 95%